Abstract
The recent increase in available G protein-coupled receptor structures now contributes decisively to the structure-based ligand design. In this context, computational approaches in combination with medicinal chemistry and pharmacology are extremely helpful. Here, we provide an update on our structure-based computational protocols, used to answer key questions related to GPCR-ligand binding. All combined, these techniques can shed light on ligand binding modes, determine the molecular basis of conformational selection, for agonists and antagonists, as well as of subtype selectivity. To illustrate each of these questions, we will consider examples from existing projects on three families of class A (rhodopsin-like) GPCRs: one small-molecule (nucleotide-like) family, i.e., the adenosine receptors, and two peptide-binding receptors: neuropeptide-Y and angiotensin II receptors. The successful application of the same computational protocols to investigate this diverse group of receptor families gives an idea of the general applicability of our methodology in the characterization of GPCR-ligand binding.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
During the processing of this manuscript one structure for the AT2 receptor (5UHN) and 2 structures for the A1 adenosine receptor (PDB codes 5N2S and 5UEN) were released.
References
Santos R, Ursu O, Gaulton A et al (2017) A comprehensive map of molecular drug targets. Nat Rev Drug Discov 16:19–34. https://doi.org/10.1038/nrd.2016.230
Stevens RC, Cherezov V, Katritch V et al (2013) The GPCR network: a large-scale collaboration to determine human GPCR structure and function. Nat Rev Drug Discov 12:25–34. https://doi.org/10.1038/nrd3859
Jazayeri A, Andrews SP, Marshall FH (2016) Structurally enabled discovery of adenosine A2A receptor antagonists. Chem Rev 117:21–37. https://doi.org/10.1021/acs.chemrev.6b00119
Kooistra AJ, Roumen L, Leurs R et al (2013) From Heptahelical bundle to hits from the haystack: structure-based virtual screening for GPCR ligands. Methods Enzymol 522:279–336. https://doi.org/10.1016/B978-0-12-407865-9.00015-7
Rodriguez D, Gutierrez-de-Teran H (2013) Computational approaches for ligand discovery and design in class-a G protein-coupled receptors. Curr Pharm Des 19:2216–2236
Fredriksson R, Lagerström MC, Lundin L-G, Schiöth HB (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63:1256–1272. https://doi.org/10.1124/mol.63.6.1256
Michino M, Abola E, GPCR Dock 2008 Participants et al (2009) Community-wide assessment of GPCR structure modelling and ligand docking: GPCR dock 2008. Nat Rev Drug Discov 8:455–463. https://doi.org/10.1038/nrd2877
Kufareva I, Rueda M, Katritch V et al (2011) Status of GPCR modeling and docking as reflected by community-wide GPCR dock 2010 assessment. Structure 19:1108–1126. https://doi.org/10.1016/j.str.2011.05.012
Kufareva I, Katritch V, Stevens RC et al (2014) Advances in GPCR modeling evaluated by the GPCR dock 2013 assessment: meeting new challenges. Structure 22:1120–1139. https://doi.org/10.1016/j.str.2014.06.012
Kristiansen K (2004) Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 103:21–80. https://doi.org/10.1016/j.pharmthera.2004.05.002
Zhukov A, Andrews SP, Errey JC et al (2011) Biophysical mapping of the adenosine A2A receptor. J Med Chem 54:4312–4323. https://doi.org/10.1021/jm2003798
Gutierrez-de-Teran H, Keränen H, Azuaje J et al (2015) Computer-aided design of GPCR ligands. Methods Mol Biol 1272:271–291. https://doi.org/10.1007/978-1-4939-2336-6_19
Chen J-F, Eltzschig HK, Fredholm BB (2013) Adenosine receptors as drug targets – what are the challenges? Nat Rev Drug Discov 12:265–286. https://doi.org/10.1038/nrd3955
Michel MC, Beck-Sickinger A, Cox H et al (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50:143–150
Zhang L, Bijker MS, Herzog H (2011) The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer. Pharmacol Ther 131:91–113. https://doi.org/10.1016/j.pharmthera.2011.03.011
Boukharta L, Gutierrez-de-Teran H, Aqvist J (2014) Computational prediction of alanine scanning and ligand binding energetics in G-protein coupled receptors. PLoS Comput Biol 10:e1003585. https://doi.org/10.1371/journal.pcbi.1003585
Xu B, Fällmar H, Boukharta L et al (2013) Mutagenesis and computational Modeling of human G protein-coupled receptor Y2 for neuropeptide Y and peptide YY. Biochemistry 52:7987–7998
Stegbauer J, Coffman TM (2011) New insights into angiotensin receptor actions: from blood pressure to aging. Curr Opin Nephrol Hypertens 20:84–88. https://doi.org/10.1097/MNH.0b013e3283414d40
Zhang H, Unal H, Gati C et al (2015) Structure of the angiotensin receptor revealed by serial femtosecond crystallography. Cell 161:833–844. https://doi.org/10.1016/j.cell.2015.04.011
Zhang H, Unal H, Desnoyer R et al (2015) Structural basis for ligand recognition and functional selectivity at angiotensin receptor. J Biol Chem 290:29127–29139. https://doi.org/10.1074/jbc.M115.689000
Zhang H, Han GW, Batyuk A, Ishchenko A, White KL, Patel N, Sadybekov A, Zamlynny B, Rudd MT, Hollenstein K, Tolstikova A, White TA, Hunter MS, Weierstall U, Liu W, Babaoglu K, Moore EL, Katz RD, Shipman JM, Garcia-Calvo M, Sharma S, Sheth P, Soisson SM, Stevens RC, Katritch V, Cherezov V (2017) Structural basis for selectivity and diversity in angiotensin II receptors. Nature 544:327–332
Sallander J, Wallinder C, Hallberg A et al (2016) Structural determinants of subtype selectivity and functional activity of angiotensin II receptors. Bioorg Med Chem Lett. https://doi.org/10.1016/j.bmcl.2015.10.084
Rodriguez D, Bello X, Gutierrez-de-Teran H (2012) Molecular modelling of G protein-coupled receptors through the web. Mol Inform 31:334–341. https://doi.org/10.1002/minf.201100162
Esguerra M, Siretskiy A, Bello X et al (2016) GPCR-ModSim: a comprehensive web based solution for modeling G-protein coupled receptors. Nucleic Acids Res 44:W455–W462. https://doi.org/10.1093/nar/gkw403
Worth CL, Kreuchwig A, Kleinau G, Krause G (2011) GPCR-SSFE: a comprehensive database of G-protein-coupled receptor template predictions and homology models. BMC Bioinform 12:185. https://doi.org/10.1186/1471-2105-12-185
Mobarec JC, Sanchez R, Filizola M (2009) Modern homology modeling of G-protein coupled receptors: which structural template to use? J Med Chem 52:5207–5216. https://doi.org/10.1021/jm9005252
Webb B, Sali A (2014) Comparative protein structure modeling using modeller. Curr Protoc Bioinformatics 47:5–6. https://doi.org/10.1002/0471250953.bi0506s47
Gutierrez-de-Teran H, Bello X, Rodriguez D (2013) Characterization of the dynamic events of GPCRs by automated computational simulations. Biochem Soc Trans 41:205–212. https://doi.org/10.1042/BST20120287
Verdonk ML, Cole JC, Hartshorn MJ et al (2003) Improved protein-ligand docking using GOLD. Proteins 52:609–623. https://doi.org/10.1002/prot.10465
Schrödinger L (2012) Schrödinger Suite 2012. doi: https://doi.org/10.3389/fphar.2015.00011/full
Nervall M, Hanspers P, Carlsson J et al (2008) Predicting binding modes from free energy calculations. J Med Chem 51:2657–2667. https://doi.org/10.1021/jm701218j
Brandsdal BO, Osterberg F, Almlöf M et al (2003) Free energy calculations and ligand binding. Adv Protein Chem 66:123–158
Keränen H, Gutierrez-de-Teran H, Aqvist J (2014) Structural and energetic effects of A2A adenosine receptor mutations on agonist and antagonist binding. PLoS One 9:e108492. https://doi.org/10.1371/journal.pone.0108492
Keränen H, Aqvist J, Gutierrez-de-Teran H (2015) Free energy calculations of a(2A) adenosine receptor mutation effects on agonist binding. Chem Commun (Camb) 51:3522–3525. https://doi.org/10.1039/c4cc09517k
Rodriguez D, Pineiro A, Gutierrez-de-Teran H (2011) Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors. Biochemistry 50:4194–4208. https://doi.org/10.1021/bi200100t
Bharate SB, Singh B, Kachler S et al (2016) Discovery of 7-(Prolinol-N-yl)-2-phenylamino-thiazolo[5,4-d]pyrimidines as novel non-nucleoside partial agonists for the A2A adenosine receptor: prediction from molecular Modeling. J Med Chem 59:5922–5928. https://doi.org/10.1021/acs.jmedchem.6b00552
Venkatakrishnan AJ, Deupi X, Lebon G et al (2013) Molecular signatures of G-protein-coupled receptors. Nature 494:185–194. https://doi.org/10.1038/nature11896
Surgand J-S, Rodrigo J, Kellenberger E, Rognan D (2006) A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors. Proteins 62:509–538. https://doi.org/10.1002/prot.20768
Gutierrez-de-Teran H, Aqvist J (2012) Linear interaction energy: method and applications in drug design. In: Barron R (ed) Computational drug discovery and design. Springer, New York, pp 305–323
Latek D, Pasznik P, Carlomagno T, Filipek S (2013) Towards improved quality of GPCR models by usage of multiple templates and profile-profile comparison. PLoS One 8:e56742. https://doi.org/10.1371/journal.pone.0056742
Sandal M, Duy TP, Cona M et al (2013) GOMoDo: a GPCRs online modeling and docking webserver. PLoS One 8:e74092. https://doi.org/10.1371/journal.pone.0074092
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
1 Electronic Supplementary Materials
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Vasile, S. et al. (2018). Characterization of Ligand Binding to GPCRs Through Computational Methods. In: Heifetz, A. (eds) Computational Methods for GPCR Drug Discovery. Methods in Molecular Biology, vol 1705. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7465-8_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7465-8_2
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7464-1
Online ISBN: 978-1-4939-7465-8
eBook Packages: Springer Protocols